GlassScriptPhysician profile
Paul M Moore
NPI 1295734515
$4,531.90
in general payments reported to CMS, 2019-2025
25 companies · $829 in 2025
The $829 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $379 · 2020: $224 · 2021: $448 · 2022: $744 · 2023: $796 · 2024: $1,111 · 2025: $829.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,613 · Travel and Lodging: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,613.16 |
| Travel and Lodging | $123.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $2,066.55 | 2019-2025 | Atricure Cryoice Cryoablation System (Cryo2), Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System |
| Medtronic, INC. | $1,293.93 | 2021-2025 | Corevalve Evolut R, Micra, Aurora Ev-Icd Mri Surescan |
| W. L. Gore & Associates, INC. | $243.48 | 2021-2024 | Gore Tag Thoracic Branch Endoprosthesis |
| Abbott Laboratories | $136.43 | 2019-2022 | |
| Medtronic Vascular, INC. | $105.15 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $97.96 | 2023 | Sternalock Blu System |
| Chiesi USA, INC. | $64.09 | 2019-2025 | Cleviprex, Kengreal |
| Abiomed | $51.95 | 2024 | Impella |
| Heartflow, INC. | $50.05 | 2025 | |
| Shockwave Medical, INC | $44.92 | 2021-2022 | |
| Stryker Corporation | $43.89 | 2023-2024 | Stryker Varispeed, Na |
| Intuitive Surgical, INC. | $41.72 | 2024 | |
| Kiniksa Pharmaceuticals, LTD. | $32.59 | 2023 | Arcalyst |
| Edwards Lifesciences Corporation | $32.04 | 2025 | Inspiris Resilia Aortic Valve |
| Abbvie INC. | $30.30 | 2023-2024 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $30.03 | 2019 | |
| Haemonetics Corporation | $28.75 | 2023 | Teg6s Hemostasis System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.86 | 2024-2025 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $22.06 | 2022 | |
| Thrombolex, INC. | $20.78 | 2024 | Bashir Endovascular Catheter |
| Inspire Medical Systems, INC. | $15.87 | 2024 | Inspire |
| Alpha Orthopedic Systems | $14.73 | 2024 | |
| Kls-Martin L.P. | $14.21 | 2024 | |
| Hemosonics LLC | $13.09 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $11.47 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.